A Phase III Trial Comparing Two Dose-dense, Dose-intensified Approaches (ETC and PM(Cb)) for Neoadjuvant Treatment of Patients With High-risk Early Breast Cancer (GeparOcto)

Clinical trial NCT02125344 · COMPLETED

Trial details

NCT number: NCT02125344
Sponsor: GBG Forschungs GmbH
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Tubular Breast Cancer Stage II Tubular Breast Cancer Stage III Mucinous Breast Cancer Stage II Breast Cancer Female NOS Invasive Ductal Breast Cancer HER2 Positive Breast Cancer Inflammatory Breast Cancer

Start date: 2014-12-01
Primary completion: 2016-11-01
Enrollment: 961

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.